Evidence map›Paper›PMID 35403367›Full record

ArticleResearch synthesis methods2022

Crowdsourcing the identification of studies for COVID-19-related Cochrane Rapid Reviews.

Anna Noel-Storr, Gerald Gartlehner, Gordon Dooley, Emma Persad, Barbara Nussbaumer-Streit

Abstract read
In one paragraph

Article in Research synthesis methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna Noel-StorrCochrane Dementia and Cognitive Improvement Group, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0003-3476-8432
Gerald GartlehnerDepartment for Evidence-Based Medicine and Evaluation, Danube University Krems, Krems an der Donau, Austria.
Gordon DooleyMetaxis Ltd., Elmbank Offices, Main Road Curbridge, Witney, Oxfordshire, UK.
Emma PersadDepartment for Evidence-Based Medicine and Evaluation, Danube University Krems, Krems an der Donau, Austria.
Barbara Nussbaumer-StreitDepartment for Evidence-Based Medicine, Cochrane Austria, Danube University Krems, Krems, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUtilisation of crowdsourcing within evidence synthesis has increased over the last decade. Crowdsourcing platform Cochrane Crowd has engaged a global community of 22,000 people from 170 countries. The COVID-19 pandemic presented an opportunity to engage the community and keep up with the exponential output of COVID-19 research.

aimsTo test whether a crowd could accurately assess study eligibility for reviews under time constraints. OUTCOME MEASURES: time taken to complete each task, time to produce required training modules, crowd sensitivity, specificity and crowd consensus.

methodsWe created four crowd tasks, corresponding to four Cochrane COVID-19 Rapid Reviews. The search results of each were uploaded and an interactive training module was developed for each task. Contributors who had participated in another COVID-19 task were invited to participate. Each task was live for 48-h. The final inclusion and exclusion decisions made by the core author team were used as the reference standard.

resultsAcross all four reviews 14,299 records were screened by 101 crowd contributors. The crowd completed each screening task within 48-h for three reviews and in 52 h for one. Sensitivity ranged from 94% to 100%. Four studies, out of a total of 109, were incorrectly rejected by the crowd. However, their absence ultimately would not have altered the conclusions of the reviews. Crowd consensus ranged from 71% to 92% across the four reviews.

conclusionCrowdsourcing can play a valuable role in study identification and offers willing contributors the opportunity to help identify COVID-19 research for rapid evidence syntheses.

Indexed as

COVID-19CrowdsourcingData CollectionHumansPandemics

Identifiers

PMID35403367
PMCPMC9088532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.